Netherlands· NL-0b697c179342
Eurartesim 160 mg/20 mg filmomhulde tabletten
A artenimol und piperaquin product containing artenimol + piperaquinetetrafosfaat 0-water, registered in Netherlands by Alfasigma S.p.A. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Artenimol und piperaquin is registered in 9 of 19 countries.
Countries holding a registration under ATC P01BF05 (artenimol und piperaquin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Artenimol und piperaquin · ATC P01BF05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ARTENIMOL + PIPERAQUINETETRAFOSFAAT 0-WATER
- Manufacturer
- Alfasigma S.p.A
- Country
- Netherlands (NL)
- ATC code
- P01BF05
- ATC class
- Artenimol und Piperaquin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/11/716
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Artenimol und piperaquin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEurartesimAlfasigma S.p.A.
- FinlandEurartesimALFASIGMA S.p.A.
- IrelandEurartesim 160 mg/20 mg film-coated tabletsSigma-Tau Industrie Farmaceutiche Riunite SpA
- IcelandEurartesimAlfasigma S.p.A.
- SpainEURARTESIM 320 mg/ 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- FranceEURARTESIM 320 mg/40 mg, comprimé pelliculéALFASIGMA (ITALIE)
- United KingdomEurartesim 320mg/40mg tabletsLogixx Pharma Solutions Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/411888f5-47c1-48bc-9517-69268b95e097 GET /v1/drugs/411888f5-47c1-48bc-9517-69268b95e097?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/eurartesim-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Artenimol and piperaquine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp105891",
"excipients": [
"CROSCARMELLOSE NATRIUM (E 468)",
"DEXTRINE",
"HYPROMELLOSE (E 464)",
"MACROGOL 400",
"MAGNESIUMSTEARAAT (E 470b)",
"TITAANDIOXIDE (E 171)",
"ZETMEEL, GEPREGELATINEERD"
],
"substances": [
"ARTENIMOL",
"PIPERAQUINETETRAFOSFAAT 0-WATER"
],
"leaflet_url": null,
"authorised_at": "2011/10/27",
"procedure_number": "EMEA/H/C/001199",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/11/716",
"additional_monitoring": "N"
}See everything about artenimol und piperaquin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.